PhoreMost Ltd., has triggered a milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first-in-class therapies, to transform patients’ lives.
Clear communication and decision-making tools boost vaccination rates in older adults
A clear endorsement from their healthcare provider and being supplied information about recommended vaccines before their clinic visit spurred more older Americans to get vaccinated,
February 13, 2025